Funding Rounds

Mogrify

Mogrify Series A (2023, $10M)

Platform enabling the development of cell therapies through advanced reprogramming techniques.

View Company Profile

Summary

Stage: Series A

Raised Amount: $10.00M

Raised Date: 2023-02-01

Investors

Parkwalk Advisors
( 20 )

Astellas Venture Management
( 19 )

Astellas Venture Management
( 19 )

Ahren Innovation Capital
( 27 )